A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma - PubMed (original) (raw)
. 1995 Apr 1;55(7):1431-5.
Affiliations
- PMID: 7882347
A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma
K Bhatia et al. Cancer Res. 1995.
Abstract
The growth arrest mediated by p53 is caused at least in part by the p53 mediated expression of p21 (p21waf1/Cip1). Since only one-third of primary Burkitt's lymphomas (BL) demonstrate mutations in the p53 gene, we examined the structural integrity of the p21 coding region by single-strand conformational polymorphism and DNA sequence analysis to determine the extent to which this gene is mutated in BL. Of 34 BLs analyzed, a frequent change (38%) at codon 31 that replaced Ser with Arg was found in 13 samples, 10 of which were from Africa. This change at codon 31 is also detected in peripheral blood DNA from normal subjects and may thus represent a polymorphism. One BL cell line, DH978, carried a change at codon 63: Phe to Leu. This mutation was heterozygous, and both the wild-type and the mutated p21 mRNA were expressed in the tumor cell line. By transfection experiments, the mutant p21 was less efficient in suppressing clonogenicity than wild-type p21. To our knowledge, this is the only mutation described in p21. The availability of this mutant p21 should further help in functional studies of p21.
Similar articles
- Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines.
Terry LA, Boyd J, Alcorta D, Lyon T, Solomon G, Hannon G, Berchuck A, Beach D, Barrett JC. Terry LA, et al. Mol Carcinog. 1996 Aug;16(4):221-8. doi: 10.1002/(SICI)1098-2744(199608)16:4<221::AID-MC6>3.0.CO;2-I. Mol Carcinog. 1996. PMID: 8784465 - Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R, Agarwal S, Mathur M, Wasylyk B, Srivastava A. Ralhan R, et al. Clin Cancer Res. 2000 Jun;6(6):2440-7. Clin Cancer Res. 2000. PMID: 10873097 - Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R. Li YJ, et al. Oncogene. 1995 Feb 2;10(3):599-601. Oncogene. 1995. PMID: 7845685 - The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia KG, Gutiérrez MI, Huppi K, Siwarski D, Magrath IT. Bhatia KG, et al. Cancer Res. 1992 Aug 1;52(15):4273-6. Cancer Res. 1992. PMID: 1638540
Cited by
- Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective.
Mainprize TG, Taylor MD, Rutka JT, Dirks PB. Mainprize TG, et al. J Neurooncol. 2001 Feb;51(3):205-18. doi: 10.1023/a:1010671908204. J Neurooncol. 2001. PMID: 11407593 Review. - Analysis of the p21 gene in gliomas.
Li YJ, Hoang-Xuan K, Zhou XP, Sanson M, Mokhtari K, Faillot T, Cornu P, Poisson M, Thomas G, Hamelin R. Li YJ, et al. J Neurooncol. 1998 Nov;40(2):107-11. doi: 10.1023/a:1006149021810. J Neurooncol. 1998. PMID: 9892092 - Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas.
Schwerer MJ, Sailer A, Kraft K, Baczako K, Maier H. Schwerer MJ, et al. J Clin Pathol. 2001 Nov;54(11):871-6. doi: 10.1136/jcp.54.11.871. J Clin Pathol. 2001. PMID: 11684723 Free PMC article. - The role of the cell cycle in genitourinary carcinoma.
McGarvey TW, Malkowicz SB. McGarvey TW, et al. World J Urol. 1996;14(5):310-7. doi: 10.1007/BF00184603. World J Urol. 1996. PMID: 8912471 Review. - Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells.
Hatshan MR, Saquib Q, Siddiqui MA, Faisal M, Ahmad J, Al-Khedhairy AA, Shaik MR, Khan M, Wahab R, Matteis V, Adil SF. Hatshan MR, et al. Int J Mol Sci. 2023 May 23;24(11):9141. doi: 10.3390/ijms24119141. Int J Mol Sci. 2023. PMID: 37298090 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous